Therapeutic agent for fibrosis
AssigneeTaiho Pharmaceutical Co., Ltd.
InventorAkio Fujioka
Life of this patent
Estimating the term…
Abstract
Provided are a therapeutic agent and a pharmaceutical composition exerting an excellent prophylactic or therapeutic effect on fibrosis and symptoms associated with fibrosis. The therapeutic agent for fibrosis comprises 4-[2-fluoro-4-[[[(2-phenylacetyl)amino]thioxomethyl]amino]-phenoxy]-7-methoxy-N-methyl-6-quinolinecarboxamide or a salt thereof as an active ingredient.
Claims8
A method for treating abnormal accumulation of a fibrous tissue in kidney, comprising administering 4-[2-fluoro-4-[[[(2-phenylacetyl)amino]thioxomethyl]amino]-phenoxy]-7-methoxy-N-methyl-6-quinolinecarboxamide or a salt thereof to a patient in need thereof.
Dependencies are inferred from the claim text.